Impact of FDA actions, DTCA, and public information on the market for pain medication
Year of publication: |
2015
|
---|---|
Authors: | Bradford, David W. ; Kleit, Andrew N. |
Published in: |
Health economics. - Chichester : Wiley-Blackwell, ISSN 1057-9230, ZDB-ID 1135838-5. - Vol. 24.2015, 7, p. 859-875
|
Subject: | FDA | prescription drugs | direct to consumer advertising | black box warnings | NSAIDs | Arzneimittel | Pharmaceuticals | Werbung | Advertising | Pharmaindustrie | Pharmaceutical industry |
-
Jae, Haeran, (2022)
-
Aikin, Kathryn J., (2021)
-
Pharmaceutical advertising and Medicare Part D
Lakdawalla, Darius, (2013)
- More ...
-
Mining and community relations in Peru : can agreement be reached?
Morales, Oswaldo, (2018)
-
Efficiencies without economists : the early years of resale price maintenance
Kleit, Andrew N., (1992)
-
Beyond the rhetoric : an inquiry into the goal of the Sherman Act
Kleit, Andrew N., (1992)
- More ...